基于网络药理学,分子对接和分子动力学模拟的雷曼尼奥西德A对系统性红斑狼的机制
Guofei Yang1, Mingfang Li1, Ying Zhang1
1Department of Dermatology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medica1 University, Guangzhou, China.
Cell biochemistry and biophysics
|July 20, 2024
概括
雷曼尼奥西德A (ReA) 通过向多种途径,显示出治疗系统性红斑狼 (SLE) 的潜力. 分子对接将mTOR确定为ReA的关键目标.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 系统性红斑狼 (SLE) 是一种复杂的自身免疫性疾病,治疗目标不清楚.
- 雷曼尼奥西德A (ReA) 是一种传统医学的化合物,已显示出潜在的生物活性,但其对SLE的影响需要阐明.
研究的目的:
- 调查雷曼尼奥西德A (ReA) 对系统性红斑狼 (SLE) 的潜在治疗机制.
- 确定关键的分子点和途径,参与REA对SLE的行动.
主要方法:
- 使用DisGeNet,GeneCards,SwissTarget和SuperPred数据库对SLE和ReA相关目标进行生物信息分析.
- 通过STRING构建和分析蛋白质与蛋白质相互作用网络.
- 基因本体学 (GO) 和KEGG通路丰富分析.
- 分子对接和分子动力学模拟以评估ReA-目标相互作用.
主要成果:
- 确定了包括HSP90AA1,HIF1A,PIK3CA,MTOR和TLR4.4在内的关键目标.
- 丰富分析揭示了重要的生物过程,如对氧化应激和活性氧物种的反应.
- 潜在的治疗途径包括PI3K-Akt信号通路,中性粒细胞外细胞陷的形成,以及亡.
- 分子对接和动力学模拟表明mTOR是主要目标,对ReA具有很高的结合亲和力.
结论:
- 雷曼尼奥西德A (ReA) 证明了系统性红斑狼 (SLE) 的多目标,多途径治疗潜力.
- 机械学的见解表明mTOR是ReA抗SLE作用的关键分子标.
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
02:40Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
01:28Structure-Activity Relationships and Drug Design
697
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
697
01:30Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K